Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Micro-Fragmented Adipose Tissue for Chronic Shoulder Pain in Spinal Cord Injury
NCT03167138Phase 1Unknown
- Sponsor
- Kessler Foundation
- Start
- Jul 2017
- Primary completion
- Sep 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous micro-fragmented adipose tissue in shoulder pain and rotator cuff disease, sponsored by Kessler Foundation. Primary endpoint: Numerical Rating Scale at 24 weeks. Status: unknown.
02
Drugs
autologous micro-fragmented adipose tissue
03
Conditions
shoulder painrotator cuff disease
Beyond the preview
Go deeper on NCT03167138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03167138.